Medications for Hormone Receptor Positive Her2 Positive Breast Cancer

2 results

  • ibrance - palbociclib capsule

    (Palbociclib)
    Pfizer Laboratories Div Pfizer Inc
    IBRANCE treats HR-positive, HER2-negative advanced or metastatic breast cancer in adults, combined with an aromatase inhibitor or fulvestrant. It also treats PIK3CA-mutated, endocrine-resistant cases with inavolisib and fulvestrant, and HR-positive, HER2-positive metastatic breast cancer with trastuzumab and endocrine therapy for maintenance.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • ibrance - palbociclib tablet, film coated

    (Palbociclib)
    Pfizer Laboratories Div Pfizer Inc
    IBRANCE treats adults with HR-positive, HER2-negative advanced or metastatic breast cancer alongside an aromatase inhibitor or fulvestrant. It also treats endocrine-resistant, PIK3CA-mutated HER2-negative metastatic breast cancer, and HR-positive, HER2-positive metastatic breast cancer as maintenance therapy with trastuzumab and endocrine therapy.
    Medication Details
    Drug Interactions